Diabetes decisions — 2022

The Veteran's diabetes mellitus, type 1, is found to be related to his active duty service and granted.

The Veteran's claim for increased disability rating for diabetic retinopathy and service connection for open angle glaucoma and cataracts is remanded due to the need for additional examinations. The TDIU issue is also remanded.

The Veteran's right knee, left knee, left hip, and right hip disabilities have been granted a 100% evaluation for the period from August 7, 2018 to August 7, 2019. The Veteran's initial evaluations for his bilateral knee and hip disabilities remain in appellate status.,The Veteran's DMII and CAD are remanded issues as they may be secondary to his service-connected knee, hip, and ankle disabilities.

The Board denied service connection for diabetes mellitus as the Veteran did not provide credible evidence of exposure to herbicide agents, including Agent Orange, during his military service.

The Veteran's claim for service connection for diabetes mellitus, Type II is granted due to exposure to herbicides during his service in Korea. The Board found that the Veteran was exposed to herbicide agents near the DMZ and thus meets the criteria for presumptive service connection.

The Board has remanded the Veteran's claims for diabetes and related conditions due to uncertainty about his exposure to Agent Orange or other potential service-related factors.

The Board has granted the appellant's application to reopen his previously denied claims for service connection for diabetes mellitus, type II and hypertension.,However, both conditions were ultimately denied as there is no evidence of herbicide exposure during service.

The Board has granted an effective date of June 17, 2014 for the assignment of a 40 percent disability evaluation for service-connected diabetes mellitus type II.

The Veteran's service-connected disabilities, including ischemic heart disease and type II diabetes mellitus, prevent him from securing or following a substantially gainful occupation. The Board has granted TDIU based on these conditions.

The Board has remanded several issues related to the Veteran's service-connected conditions, including diabetes mellitus, right knee arthritis, peripheral neuropathy, and shoulder dislocation. The TDIU claim is also being remanded due to inextricably intertwined increased rating claims.

The Board has decided to remand the case due to insufficient evidence regarding the etiology of the Veteran's kidney disorder, specifically whether it is related to service or his diabetes.

The Board has remanded the Veteran's claim of entitlement to a higher rating for his service-connected diabetes mellitus due to insufficient evidence from a recent VA examination. The Veteran is required to undergo another VA examination to assess the current severity and functional impairment caused by his diabetes.

The Board has determined that the Veteran's diabetes mellitus type II began during his active duty service and granted service connection for this condition.

The Board has remanded the cases for additional development, including obtaining a VA opinion regarding whether the Veteran's diabetes mellitus, hypertension, and left ankle tendonitis were aggravated by his service-connected disorders.

The Board has remanded the case due to a need for an additional VA medical opinion addressing whether the Veteran's service-connected acquired psychiatric disorder and/or medications have aggravated his nonservice-connected diabetes mellitus.

The Board has remanded the Veteran's claims for an initial rating in excess of 10 percent for diabetic peripheral neuropathy of both lower extremities due to a lack of recent VA treatment records and the need for a new examination.

The Board has remanded the claims for service connection for diabetes and ED as secondary to diabetes due to in-service herbicide exposure. Additional evidence is needed, including VA treatment records from Gainesville, Florida, and a VA examination to determine if there is a relationship between the Veteran's diabetes and his military service.

The Board has remanded the cases for further development and consideration, including scheduling a VA examination for the respiratory disability claim and issuing an SSOC regarding diabetes mellitus.

The Veteran's residuals of prostate cancer are rated at 60 percent, and the appeal for a higher rating is denied. The Veteran was also denied TDIU from July 1, 2017 to December 11, 2017.

The Board has remanded the case due to a lack of medical evidence for the period before May 5, 2016, and needs a retrospective medical opinion to determine when the Veteran's vision worsened.